Target intelligence / Profile preview

LHFPL tetraspan subfamily member 5 protein (LHFPL5)

Target
LHFPL5
Molecular classification
Tetraspan transmembrane protein, Auxiliary subunit of mechanotransducer (MET) channel complex, Other (not a major classical drug target family)
01

Overview

LHFPL tetraspan subfamily member 5 protein (LHFPL5) is a four-transmembrane domain protein in the tetraspan superfamily, acting as an auxiliary subunit of the mechanotransducer (MET) cation channel complex at the tips of stereocilia in cochlear hair cells[10][2][3]. It is essential for sensory transduction in the auditory system by facilitating the functional assembly and trafficking of the MET channel complex, coupling PCDH15 to the transduction channel, and ensuring the correct morphogenesis of hair bundles. Pathogenic mutations in LHFPL5 result in autosomal recessive nonsyndromic sensorineural hearing loss (DFNB67) in humans and corresponding deafness and vestibular phenotypes in animal models[1][2][3][7][11][10]. No approved drugs target LHFPL5, and it is not currently considered a direct therapeutic target for pharmacological intervention.

Other names
TMHSDFNB67dJ510O8.8Lipoma HMGIC fusion partner-like 5Tetraspan membrane protein of hair cell stereociliaLHFP-like protein 5MGC33835
02

Biological functions

Mechanosensory transduction in inner ear hair cellsHair bundle morphogenesisSensory perception of sound
03

Disease associations

Deafness (autosomal recessive nonsyndromic sensorineural hearing loss, DFNB67)Vestibular dysfunction (in animal models)Other (possibly intellectual developmental disorder)
04

Safety considerations

Mutations cause congenital deafnessImpacts auditory mechanotransduction; no drug safety concerns described

Beyond the preview

Go deeper on LHFPL tetraspan subfamily member 5 protein (LHFPL5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LHFPL tetraspan subfamily member 5 protein (LHFPL5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call